Healthcare Supply Chain Management Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2027

 The need for speedy distribution of healthcare products and services is of critical importance, thus boosting the healthcare supply chain management market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The worldwide market is projected to record an 8.2 % CAGR in the forecast period.

The creation of a strong competitive logistics infrastructure is estimated to guide the advance of the healthcare supply chain management market companies in the future. The availability of funding and customization is estimated to further boost the healthcare supply chain management market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5716 

Segmental Analysis

The segmental evaluation of the healthcare supply chain management market is carried out based on models, function, delivery mode, technology, software, end-users, and region. The models segment of the healthcare supply chain management market has been segmented into continuous replenishment model, make-to-stock model, build-to-order, and chain assembly. The technology segment of the healthcare supply chain management market has been segmented into radio frequency identification (RFID), a barcode, global positioning system (GPS), the internet of things, and big data. The function segment of the healthcare supply chain management market has been segmented into inventory management and procurement, warehousing, and distribution, forecasting and planning, internal logistics and operations, reverse and extended logistics. The region segment of the healthcare supply chain management market has been segmented into Europe, the Middle East, Asia Pacific, the Americas, and Africa. The software segment of the healthcare supply chain management market has been segmented into execution tools and planning tools. The end users’ segment of the healthcare supply chain management market has been segmented into logistics companies and distributors, healthcare providers, and pharmaceutical and biotech companies. The delivery mode segment of the healthcare supply chain management market has been segmented into web-based and on-premise.

Detailed Regional Analysis 

The regional examination of the healthcare supply chain management market has been segmented into Europe, the Middle East, Asia Pacific, the Americas, and Africa. The Americas’ healthcare supply chain management market is anticipated to dominate the global market due to the presence of a large presence of eminent biotech and pharmaceutical companies, an advanced healthcare sector, along with government proposals, and the upsurge in demand for medical devices. The European region is one of the world’s foremost exporter of medicinal and pharmaceutical products and the upsurge in export and import for healthcare-related products will augment the market in this region. The Asia Pacific healthcare supply chain management market due to the increasing incidence of prolonged illness and an upsurge in the call for pharmaceutical products & medical devices is likely to develop quickly.

Competitive Analysis

The market is appraised to be stimulated by an increased development upsurge that is bracing the contenders who are active in the market. The competition in the market is estimated to flare-up following the disruption created by the COVID- pandemic. The emphasis on ensuring sustainability in long-term operations is estimated to be a key cause for development in the upcoming period. The trends in the market are estimated to bolster the progress in the worldwide market. The tendency to invest and expand capacities is estimated to create a promising scope for the market in the impending years. The change in several regulations that are running the development of the market is estimated to impact the innovations that can be seen in the global market. The increased contribution of online channels towards the swell in transactions is predicted to further encourage the advancement of the market in the future. The government intervention in the creation of opportunities that can incentivize the development of key regions in the market is predicted to further add an optimistic touch to the proceedings in the market.

The promising contenders in the healthcare supply chain management market are GHX (US), Infor (US), Oracle (US), Advocate Health Care (Murray, UT), TECSYS (Canada), McKesson (US), SAP (Germany), Manhattan Associates (US), LogiTag Systems (Israel), Jump Technologies (US), JDA Software (US), and others.

Industry Updates:

Mar 2021 SATO, an international auto-ID solutions supplier, introduced the CT4-LX-HC compact desktop printer to tackle healthcare identification needs in the healthcare supply chain. SATO's smart connectivity solution includes feedback from operators on the business's front lines to reduce the stress connected to firmware updates, making settings, and handling label designs for efficient printing of labels to circumvent medical incidents.

Mar 2021 McKesson Corporation, a worldwide healthcare business, revealed a new partnership with Vanderbilt Health Rx Solutions (VHRxS), a nationwide leader in specialty pharmacy strategy and application, to advance VHRxS’s full suite of specialty pharmacy consulting services to McKesson’s health system customers. This new, dedicated offering from VHRxS will balance the experience of McKesson, which has presented industry-leading pharmacy services.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716 

Throat Lozenges Market Foraying into Emerging Economies 2023

 The use of throat lozenges has increased considerably due to the uptick in the occurrence of cold and cough cases globally. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The market stands to gain a 4.20% CAGR and produce a market worth of USD 6.58 Billion by the conclusion of 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1212 

Throat lozenges are being preferred increasingly as they are a convenient option for treating cough, thus spurring the throat lozenge market. The availability of throat lozenges as over-the-counter drugs is estimated to play a vital role in market expansion in the impending period.

Segmental Analysis

The segmental review of the throat lozenge market is carried out on the basis of types, ingredients, indications, and region. The indication segment of thethroat lozenges market consists of cough and cold, sore throat, and throat diseases. The ingredient segment of the throat lozenge market consists of mint, menthol, eucalyptus oil, honey & ginger, lemon, and peppermint oil. The types segment of the throat lozenge market consists of compressed lozenges, soft lozenges, and hard candy lozenges. The regions included in the throat lozenge market are Europe, the Americas, Asia Pacific, and other key regional markets.

Detailed Regional Analysis 

The regional investigation of the throat lozenge market includes regions such as Europe, the Americas, Asia Pacific, and other key regional markets. The regions of North America and South America are generally divided in the Americas, with a segment of over 70 % in the North American regional market’s share. Owing to the appearance of a progressively aging demographic, the Americas regional market for throat lozenges is the chief regional customer segment. Furthermore, the intensifying government expenditure and the incidence of an extensive range of product options are pushing the throat lozenge market. The advance of the European region’s demand for throat lozenges is inspired by the emergence of a substantial number of suppliers of throat lozenges, along with expanding government expenditure and the accessibility to a wide range of product offerings. It is estimated that the Asia Pacific throat lozenge market will be the fastest growing with a 4.77% CAGR through the forecast period. Developing markets such as China, Japan, and India are among the notable markets in the region. The main factors of the APAC throat lozenge market growth are speedy economic expansion, understanding of over-the-counter medicine, and cost-effectiveness.

Competitive Analysis

The trends in the market are estimated to bolster the progress in the worldwide market. The tendency to invest and expand capacities is estimated to create a promising scope for the market in the impending years. The change in several regulations that are running the development of the market is estimated to impact the innovations that can be seen in the global market. The increased contribution of online channels towards the swell in transactions is predicted to further encourage the advancement of the market in the future. The government intervention in the creation of opportunities that can incentivize the development of key regions in the market is predicted to further add an optimistic touch to the proceedings in the market. The market is appraised to be stimulated by an increased development upsurge that is bracing the contenders who are active in the market. The competition in the market is estimated to flare-up following the disruption created by the COVID- pandemic. The emphasis on ensuring sustainability in long-term operations is estimated to be a key cause for development in the upcoming period.

Prestige Brands Inc, Reckitt Benckiser Group plc, Wrigley Company, Gepach International, Procter & Gamble, Bliss GVS Pharma Ltd, Pfizer Inc., Thornton & Ross, Bausch Health Companies Inc, Ricola AG, Ernest Jackson, Mondelēz International group, GlaxoSmithKline, Doestsch Grether AG are some of the primary companies in the throat lozenge market.

Industry Updates:

Feb 2021 The College of Health and Agricultural Sciences of Africa University has made progress in advancing throat lozenges concocted from the zumbani plant, which many Zimbabweans have been sourcing as part of home remedies to combat Covid 19. The novel product, zumbani medicinal cough drops, is projected to help in improving the immune system to fight the disease.

Dec 2020 Applied Biological Laboratories, a New York biotechnology business has introduced Biovanta, the lone drug in the cold, cough, and sore throat category prepared from 100% natural ingredients.  Biovanta is verified as a superior alternative to other important products at checking upper respiratory inflammation as revealed in blind, third-party, placebo-controlled laboratory studies. Biovanta controls cytokines and fortifies the respiratory lining. Important inflammatory molecules examined include bradykinin, which is linked in the cytokine storm-related with COVID-19 and other serious upper respiratory diseases.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212 

Patient Handling Equipment Market Foraying into Emerging Economies 2020-2027

 Global Patient Handling Equipment Market size is expected to be valued at USD 15,430.18 Million by 2027 at a CAGR of 8.3% during the forecast period, 2020-2027.

The advancement in patient handling equipment and expansion of healthcare infrastructure due to the COVID-19 pandemic is expected to boost the growth of the market in the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

An increasing usage of patient handling equipment in hospitals, rehabilitation centers, and elderly care settings is expected to drive the growth of the global patient handling equipment market.

The market growth in the coming years can also be attributed to the business expansion of manufacturers through merger & acquisition and incessant launch of innovative products. For instance, in the year 2020, Invacare Corporation, a US-based long-term medical product manufacturer, announced the launch of an Invacare AVIVA FX Power Wheelchair, a front-wheel-drive wheelchair. This product launch was aimed to strengthen the company’s power mobility product portfolio.

Market USP

Growing patient population of chronic diseases and rising geriatric population are the major market influencer of the patient handling equipment market.  

Market Drivers

The rising influx of patients in the hospital due to an outbreak of COVID-19 pandemic. The critical care products including hospital beds, ventilators, and vitals monitoring devices are being used in abundance for patients suffering from COVID-19. Various companies are aiding the healthcare sector in meeting the rising demand for critical care products by increasing their manufacturing capacity. For instance, in May 2020, Stryker (US) delivered about 1,000 emergency relief beds to hospitals in Qatar. The company is also massively producing emergency relief beds, a low-cost hospital bed.      

• Increasing geriatric and obese population

• Risk of injuries to caregivers while manual handling of patients

• Implementation of regulations to ensure the safety of healthcare service providers during the manual lifting procedure. For instance, according to the Office of State Human Resources (OSHR), the caregiver should do a preliminary assessment of their safety & health risks before any manual handling operation and take appropriate steps to lower the risks of patient handling. Also, manual handling operations should be avoided as far as it is reasonably practicable.

• A growing number of road accidents

• Growing usage of ceiling lifts in hospitals

Market Restraints

• Low skilled professionals for the efficient operation of the patient handling equipment.

Segmentation

By Product

• Patient Transfer Devices: This segment is likely to hold the largest share owing to the growing number of obese patients. This segment is further fragmented into patient lifts, air-assisted lateral transfer mattresses, sliding sheets, and accessories. Patient transfer devices aid in long and short distance transfer of patients depending on the requirement. Also, these products provide caregivers reduced risk of injuries while patient handling and are time efficient. According to National Public Radio, every year about 35,000 nursing professionals experience back and body injuries during patient handling in the US region.

• Medical Beds: This segment is further segmented into manual beds, electric beds, and semi-electric beds. The rising number of COVID-19 patients has influx the demand for medical beds in the forecast period. Also, the growing geriatric population base susceptive to chronic disease will be driving the growth of the segment. For instance, in 2019, according to the United Nations, globally there were about 703 million people aged 65 or over.

• Mobility Devices: This segment is further segmented into wheelchairs & mobility scooters, and ambulatory aids. The increasing cases of disability are expected to propel the demand for mobility devices. The ambulatory aid equipment provides support, stability, and balance for patients. The ambulatory aid segment includes equipment such as crutch, cane walking, walker, and others.

• Bathroom & Toilet Assist Equipment: These segments include bathroom assist products such as commodes, bath aids, handgrips, bath lifts, shower chairs, and others. Easy availability in online stores is likely to propel the growth of the segment.

• Stretchers & Transport Chairs: These are used in carrying patients from one place to another, within and outside of a healthcare facility. The advancement in stretchers & transport chairs has been enabling clinicians in providing patients with proper emergency assistance.

By Application

• Acute & Critical Care: This segment is likely to hold the largest share owing to high prevalence rate cardiovascular diseases, viral infection, and other acute diseases. For instance, in 2017, according to the Centers for Disease Control and Prevention (CDC), about 18.2 million adult population aged 20 or older were suffering from coronary heart disease in the US region.

• Long Term Care: This segment is likely to be the fastest-growing segment owing to the growing prevalence of target diseases such as tuberculosis, Alzheimer’s disease, tetanus, and others. For instance, according to Alzheimer's Association, in the US, about 5.8 million people aged 65 or above were suffering from Alzheimer’s dementia in 2019 and 5.7 million in 2018.

• Mobility Assistance: The growth of this segment can be attributed to the growing incidence rate of diseases such as arthritis and Parkinson’s.  For instance, according to Parkinson's Foundation, every year about 60,000 of the American population are diagnosed with Parkinson’s disease. This disease is characterized by stiffness, slowed movement, tremors, and impaired balance. The mobility assistance devices improve balance and provide support to patients suffering from Parkinson’s disease. Also, the rising elderly population is expected to drive the growth of the segment.

By End-User

• Hospitals: Hospitals segment dominated the market share owing to increasing healthcare infrastructure and rising investment. According to MRFR analysis, the investments made in hospital and healthcare services for the year 2017 and 2018 in some European countries are the following:

By Region

• Americas: The largest regional market. The increasing prevalence rate of obesity is expected to boost the growth of the market during the forecast period. For instance, in the US, according to the Centers for Disease Control and Prevention (CDC), in 2017-18, the prevalence of obesity was around 42.2%, which was about 39.8% in 2015-16.

• Europe: Europe held the second-largest position in the patient handling equipment market owing to high research and development investment. For instance, in 2017, according to MedTech Europe, about 40% of total patent applications in medical technology were filed from European countries.

• Asia-Pacific: The fastest-growing regional market for patient handling equipment owing to the growing life expectancy rate. According to the World Bank, the life expectancy at birth in the South Asia region in 2017 and 2018 were 69.1 year and 69.4 years, respectively. Also, growing healthcare expenditure is driving the growth of the market. For instance, in 2017, according to the World Bank, the healthcare expenditure of Japan, China and India was about 10.94%, 5.15%, and 3.53%, respectively. Such increasing expenditure backed by life expectancy rate is expected to boost the demand for patient handling devices in the coming years

• Middle East & Africa: This region is expected to show steady growth owing to the high rate of obesity. For instance, in 2016, according to the World Health Organization, about 28.3% of adults and 81.3% of women are suffering from obesity in the South African region. However, low healthcare infrastructure in the region is expected to hinder the market growth in the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

Global Nebulizers Market 2020 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast By 2027

 Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the market growth. Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9586 

According to MRFR analysis, the Global Nebulizers Market size is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027.

A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine.

The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19.

Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period.

However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market.

Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User.

Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers.

On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users.

Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use.

The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players

Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nebulizers-market-9586 

Biopharmaceuticals Market Size, Forecast 2027 Industry Chain Analysis, Segmentation, Opportunities with Top Applications

 Biopharmaceuticals are medical drugs produced using biotechnology. Biopharmaceuticals can be proteins (including antibodies), nucleic acids (DNA, RNA, or antisense oligonucleotides) that are used for therapeutic or in vivo diagnostic purposes. These are produced by various means, including direct extraction from a native (non-engineered) biological source. The first such biopharmaceutical approved for therapeutic use was recombinant human insulin (RHI, trade name Humulin), which was developed by Genentech and marketed by Eli Lilly and Company in 1982. Growing market demand for biopharmaceuticals, rising investment by major companies on research & development of biopharmaceuticals, the high incidence rate of chronic diseases, and increasing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases is expected to drive the market growth. As of September 2019, approximately six in 10 adults in the US suffer from a chronic disease. Moreover, rising geriatric population and increasing technological advancements are also anticipated to fuel the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8439 

Biopharmaceuticals Market size is expected to hold a value of USD  471,021.1 Mn by 2027 at a CAGR of 9.13%.

Segmentation

The global biopharmaceuticals market has been segmented based on product type and application.

The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases.

The market based on application has been segmented into oncology, inflammatory & infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, disease prevention, cardiovascular diseases, neurological diseases, and others. The oncology segment is expected to hold the largest share of the market due to the high prevalence of cancer. In 2019, 606,880 cancer-related deaths occurred in the US. The neurological diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of neurological disorders such as Parkinson’s disease and epilepsy. Nearly 60,000 people in America are diagnosed with Parkinson’s disease every year.

Key Players

Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439 

Rising Production Scale Motivates Drug Discovery Informatics Market 2027 Growth in the Coming Years

 Global drug discovery informatics market size is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% during the forecast period. Drug discovery and development is a highly intricate process requiring the generation of very large amounts of data and information. Large amounts of data are generated using a variety of innovative technologies, and the limiting step is accessing, searching and integrating this data. The current approaches to collect information from various sources have been dealt with in some cases where the data types are very least well-defined or largely homogeneous.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7831 

However, the world is on the verge of a new age of drug discovery informatics, the methods and approaches in which are dealing with gathering information from data and knowledge from information are undergoing a paradigm shift. Mining and integration of domain-specific information such as chemical and genomic data will continue to develop in the near future. Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process. Some of the factors driving the market growth are a rising worldwide focus on drug discovery, growing need to control drug discovery and development costs, growth in R&D expenditure, and increasing burden of chronic diseases. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. On the other hand, high pricing and setup cost of informatics software is anticipated to restrict the market growth during the forecast period.

Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth. It involves different steps and procedures which depend on in-silico tools for reducing the complexity of the process. In-silico tools include modeling tools for the determination of 3D structures of ligand and protein-absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Regional Analysis

The global drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to hold higher market share over the forecast period pertaining to the presence of market value contributors, burgeoning pharmaceutical and biotechnology vertical, and rising prevalence of chronic diseases in the US and Canada. For instance, as per statistics published by the Center for Disease Control and Prevention (CDC), about 610,000 people die due to heart disease in the US every year (one in every four deaths).

Europe would follow the Americas in terms of value in the drug discovery informatics market owing to a surge in the clinical discovery ventures coupled with various activities conducted by research institutes, universities, and centers. The federal government acts as a regulator and also insures some public employees in Germany. Around 16 states in this county maintain public hospitals. The German government also proposes many healthcare programs to make citizens aware of the fatal disease.

Asia-Pacific would represent the fastest market growth during the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region.

The Middle East & Africa has the least share of the global drug discovery informatics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

Key Players

Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/drug-discovery-informatics-market-7831 

Healthcare Information Systems Market – Comparative Analysis by 2027

 The global healthcare information systems market size is expected to register a CAGR of 10.0% during the forecast period of 2018 to 2023.

Healthcare information technology offers solutions for security and data management of information related with healthcare. Currently, information technology has more effect on the cost quality and safety associated with healthcare. Some commonly used applications in the healthcare industry include electronic medical records, healthcare records and personal health records.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7325 

Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors. The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times. Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.

Segmentation

The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.

On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.

Regional Analysis

The Americas leads the global healthcare information systems market. This can be attributed due to growing elderly population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.

 In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global healthcare information systems market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.

Key Players

Some of the key players in the global healthcare information systems market are Agfa-Gevaert N.V.

Allscripts Healthcare Solutions Inc., Athenahealth Inc., Carestream Health, Cerner Corporation

GE Healthcare, McKesson Corporation, Medidata Solutions Inc., NextGen Healthcare, Philips Healthcare, Siemens Healthineers.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325